Citation Impact
Citing Papers
The gut microbiota and host health: a new clinical frontier
2015 Standout
Upregulation of microRNA-126 in Hepatic Stellate Cells May Affect Pathogenesis of Liver Fibrosis Through the NF-κB Pathway
2015
Ligand-tethered lipid nanoparticles for targeted RNA delivery to treat liver fibrosis
2023 StandoutNobel
Bile acid–microbiota crosstalk in gastrointestinal inflammation and carcinogenesis
2017 Standout
GIV/Girdin is a central hub for profibrogenic signalling networks during liver fibrosis
2014
A role for autophagy during hepatic stellate cell activation
2011
Hepatic stellate cells as key target in liver fibrosis
2017
Role of Obesity and Lipotoxicity in the Development of Nonalcoholic Steatohepatitis: Pathophysiology and Clinical Implications
2012
Non-alcoholic fatty liver disease – A global public health perspective
2018 Standout
Genetic Predisposition in NAFLD and NASH: Impact on Severity of Liver Disease and Response to Treatment
2013
Non-invasive monitoring of chronic liver disease via near-infrared and shortwave-infrared imaging of endogenous lipofuscin
2020 StandoutNobel
Genetic modifiers of non-alcoholic fatty liver disease progression
2011
Mechanisms of hepatic stellate cell activation
2017 Standout
Increased Angiogenesis Protects against Adipose Hypoxia and Fibrosis in Metabolic Disease-resistant 11β-Hydroxysteroid Dehydrogenase Type 1 (HSD1)-deficient Mice
2011 StandoutNobel
Human Genetics Shape the Gut Microbiome
2014 Standout
NF-κB in the liver—linking injury, fibrosis and hepatocellular carcinoma
2011
Hepatic Stellate Cells and Liver Fibrosis
2013
The perilipin family of lipid droplet proteins: Gatekeepers of intracellular lipolysis
2017 Standout
Interleukin-15 receptor α on hepatic stellate cells regulates hepatic fibrogenesis in mice
2016
Bacterial translocation and changes in the intestinal microbiome in mouse models of liver disease
2012
Liver fibrosis: mechanisms of immune-mediated liver injury
2011
Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention
2017 Standout
The XBP1 Arm of the Unfolded Protein Response Induces Fibrogenic Activity in Hepatic Stellate Cells Through Autophagy
2016
In vivo genome-wide profiling of RNA secondary structure reveals novel regulatory features
2013 Nature
Macrophages: Master Regulators of Inflammation and Fibrosis
2010 Standout
Hepatocellular carcinoma
2021 Standout
Effect of adipose tissue insulin resistance on metabolic parameters and liver histology in obese patients with nonalcoholic fatty liver disease
2011
Bacterial translocation and changes in the intestinal microbiome associated with alcoholic liver disease
2012
Autophagy Releases Lipid That Promotes Fibrogenesis by Activated Hepatic Stellate Cells in Mice and in Human Tissues
2012
Endoplasmic reticulum stress induces fibrogenic activity in hepatic stellate cells through autophagy
2013
Resveratrol Reduces the Proinflammatory Effects and Lipopolysaccharide- Induced Expression of HMGB1 and TLR4 in RAW264.7 Cells
2014 Standout
Virus associated malignancies: The role of viral hepatitis in hepatocellular carcinoma
2014 StandoutNobel
Mechanisms of NAFLD development and therapeutic strategies
2018 Standout
Pericytes: Developmental, Physiological, and Pathological Perspectives, Problems, and Promises
2011 Standout
The importance of antioxidants which play the role in cellular response against oxidative/nitrosative stress: current state
2015 Standout
Evolving challenges in hepatic fibrosis
2010
Mechanisms of Hepatic Fibrogenesis
2008 Standout
The Impact of the Gut Microbiota on Human Health: An Integrative View
2012 Standout
Epithelial-Mesenchymal Interactions in Biliary Diseases
2011
Insights into RNA structure and function from genome-wide studies
2014 StandoutNobel
Molecular Mechanisms of Alcoholic Liver Disease: Innate Immunity and Cytokines
2011
Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial
2014 Standout
Genetic Factors That Affect Risk of Alcoholic and Nonalcoholic Fatty Liver Disease
2016
ATGL and CGI-58 are lipid droplet proteins of the hepatic stellate cell line HSC-T6
2015
Massive gene amplification drives paediatric hepatocellular carcinoma caused by bile salt export pump deficiency
2014
Alcoholic Liver Disease: Pathogenesis and New Therapeutic Targets
2011 Standout
N6-methyladenosine-dependent RNA structural switches regulate RNA–protein interactions
2015 StandoutNature
Astaxanthin prevents and reverses the activation of mouse primary hepatic stellate cells
2015
The human microbiome: at the interface of health and disease
2012 Standout
AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease
2023 Standout
The Genetics of Nonalcoholic Fatty Liver Disease: Spotlight on PNPLA3 and TM6SF2
2015
The role of cancer-associated myofibroblasts in intrahepatic cholangiocarcinoma
2011
Intestinal permeability – a new target for disease prevention and therapy
2014 Standout
Liver X receptors balance lipid stores in hepatic stellate cells through Rab18, a retinoid responsive lipid droplet protein
2014
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
2017 Standout
Metagenomics of the Human Body
2010
The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review
2023 Standout
Marine natural products
2018 Standout
Fibrosis — A Common Pathway to Organ Injury and Failure
2015 Standout
Inflammatory responses and inflammation-associated diseases in organs
2017 Standout
Innate immunity in alcoholic liver disease
2011
Liver inflammation and fibrosis
2017
Chronic Inflammation and Cytokines in the Tumor Microenvironment
2014 Standout
Current status of novel antifibrotic therapies in patients with chronic liver disease
2011
Macrophage plasticity, polarization, and function in health and disease
2018 Standout
Wound healing - A literature review
2016 Standout
Hepatic toll‐like receptor 4 expression is associated with portal inflammation and fibrosis in patients with NAFLD
2014
Works of Johnny Loke being referenced
Functional linkage of cirrhosis‐predictive single nucleotide polymorphisms of toll‐like receptor 4 to hepatic stellate cell responses†‡
2008
Ras Promotes Growth by Alternative Splicing-Mediated Inactivation of the KLF6 Tumor Suppressor in Hepatocellular Carcinoma
2008
Hepatic stellate cells express functional CXCR4
2009
Downregulation of hepatic stellate cell activation by retinol and palmitate mediated by adipose differentiation‐related protein (ADRP)
2010
Compilation of mRNA Polyadenylation Signals in Arabidopsis Revealed a New Signal Element and Potential Secondary Structures
2005